Chinese pharmaceutical company China Health Resource has signed a letter of intent with Sichuan Zhiyuan Aquarious, a leading pharma enterprise in China. China Health Resource is well known for its high-quality Angelica in the native market of Sichuan, encouraging many dealers and pharmaceutical enterprises, both local and abroad, to work closely with the company in a long-term agreement for the supply of Angelica. In addition, the company has received GAP certification for Angelica production and exclusive use of "Sichuan Angelica", the geographical logo. "As we continue the development and additions of new uses for DAR, we remain focused on exploring opportunities that will ensure a successful and stable future for our company," stated Mr Jiayin Wang, CEO, China Health Resource. "Signing this Letter of Intent with such a respectable company within the Chinese pharmaceutical industry further strengthens our promising outlook for a successful 2011." The Letter of Intent provides in pertinent part, that Sichuan Zhiyuan Aquarious Pharmacy Co., Ltd purchase a quantity of Angelica exceeding 300,000 kilograms (330 tons), guaranteeing China Health Resource more than $800,000 income for 2011. The companies anticipate the signing of the final binding Sales Contract. Sichuan Zhiyuan Aquarious has more than 50 stores in China, and has established relationships with various dealers in the United States, Australia and several other countries.